Vimarsana
Biggest News Aggregation in the World

Page 30 - Cell Stem News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Stem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Stem Today - Breaking & Trending Today

Type of fat in breast milk might hold cure to preventing and treating cerebral palsy, study says - Vimarsana News

Type of fat in breast milk might hold cure to preventing and treating cerebral palsy, study says

A study from Duke University medical experts suggested that a fatty molecule found in breast milk could prevent and reverse the motor disorder cerebral palsy in premature infants

Cloning Fast Facts - Vimarsana News

Cloning Fast Facts

Read CNN’s Cloning Fast Facts and learn more about the process of creating a genetically identical copy of an original.

Source: cnn.com
Postdoctoral Scientists, Associate Research Scientists, or Research Scientists job with Yale School of Medicine (YSM) - Vimarsana News

Postdoctoral Scientists, Associate Research Scientists, or Research Scientists job with Yale School of Medicine (YSM)

Postdoctoral Scientists, Associate Research Scientists, or Research Scientists in Full time, Postdoctoral, Biomedicine with Yale School of Medicine (YSM). Apply Today.

Source: nature.com
Stem Cells-developed Embryo-like Models Used To Understand Earliest Stages Of Human Development - Vimarsana News

Stem Cells-developed Embryo-like Models Used To Understand Earliest Stages Of Human Development

Cambridge scientists have created a stem cell-derived model of the human embryo in the lab by reprogramming human stem cells. The breakthrough could help research into genetic disorders and in understanding why and how pregnancies fail.Our human embr

European Patent Office Grants ONK Therapeutics' - Vimarsana News

European Patent Office Grants ONK Therapeutics'

The European Patent Office (EPO) has granted WEHI a patent for CISH knockout (KO) in Natural Killer (NK) cells which is exclusively licensed to ONK...